SCFA can inhibit NF-κB and tumor necrosis factor (TNF) signaling pathway, resulting in the decrease of expression of VCAM-1 and ICAM-1, thus inhibiting the development of atherosclerosis [104]. This evidence concerns the gene TNF and atherosclerosis.